Prolactinoma
Showing 1 - 25 of 39
Exercise Capacity and Physical Activity Level in Prolactinoma
Completed
- Prolactinoma
-
Ankara, TurkeyHacettepe University
Oct 29, 2022
Pituitary Tumors and Related Hypothalmic Disorders
Recruiting
- Panhypopituitarism
- +3 more
- MRI
- Tissue specimen collection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Validation of a Quality of Life Metric "Prolac-10"
Recruiting
- Prolactinoma
- +4 more
-
Columbus, OhioOhio State University
Jun 20, 2021
Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)
Completed
- Hyperprolactinemia
- Prolactinoma
-
New York, New YorkColumbia University Medical Center
Jul 9, 2021
Prolactinoma, Prolactin-Producing Pituitary Tumor Trial in Amsterdam-Zuidoost, Delft, Leiden (Endoscopic trans-sphenoidal
Recruiting
- Prolactinoma
- Prolactin-Producing Pituitary Tumor
- Endoscopic trans-sphenoidal adenoma resection
- Dopamine Agonists
-
Amsterdam-Zuidoost, Noord-Holland, Netherlands
- +2 more
Jul 17, 2020
Pituitary Adenoma, Prolactinoma, Pituitary Tumor Trial in Seoul (Cabergoline)
Recruiting
- Pituitary Adenoma
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 17, 2020
Seoul National University Pituitary Disease Cohort Study
Recruiting
- Pituitary Disease
- +7 more
- Dynamic hormone study and Magnetic resonance imaging
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 17, 2020
Pituitary Adenomas, Prolactinomas Trial in Los Angeles, Baltimore, Boston (Lapatinib)
Completed
- Pituitary Adenomas
- Prolactinomas
-
Los Angeles, California
- +2 more
Jan 13, 2020
Long Term Outcome Study in Patients With Pituitary Disorders
Active, not recruiting
- Pituitary Diseases
- Pituitary Neoplasms
- (no location specified)
Jan 30, 2023
Prolactinoma Trial (Surgery, Drug treatment)
Unknown status
- Prolactinoma
- Surgery
- Drug treatment
- (no location specified)
Nov 19, 2018
Genetics of Endocrine Tumours - Familial Isolated Pituitary
Recruiting
- Acromegaly
- +5 more
-
London, United Kingdom
- +1 more
Oct 17, 2022
Craniopharyngioma, Obesity Trial in Oldenburg
Recruiting
- Craniopharyngioma
- Obesity
-
Oldenburg, Niedersachsen, GermanyKlinikum Oldenburg
Mar 29, 2022
Pituitary Adenoma Trial in London (Intraoperative ultrasound)
Recruiting
- Pituitary Adenoma
- Intraoperative ultrasound
-
London, United KingdomNational Hospital for Neurology and Neurosurgery
Apr 26, 2021
Resistance, Disease, Prolactinoma Trial in China (HCQ/CQ and CAB combined treatment)
Unknown status
- Resistance, Disease
- Prolactinoma
- HCQ/CQ and CAB combined treatment
-
Beijing, Beijing, China
- +8 more
Oct 14, 2018
Rhinological Outcomes in Endonasal Pituitary Surgery
Completed
- Pituitary Neoplasm
- +4 more
-
Phoenix, Arizona
- +3 more
Aug 21, 2018
Pituitary Tumours: Prevalence of Associated Neoplasia
Recruiting
- Pituitary Tumor
- +4 more
- Registration of familial forms and associated neoplasia
-
Pozzilli, IS, ItalyNeuromed
Aug 31, 2021
Prolactinoma Trial in Guangzhou (transsphenoidal surgery treatment, dopamine agonist treatment)
Recruiting
- Prolactinoma
- transsphenoidal surgery treatment
- dopamine agonist treatment
-
Guangzhou, ChinaSun Yat-sen 5010 program
Nov 20, 2017
Type 1 Diabetes Trial in Aurora (Bromocriptine, Placebo)
Completed
- Type 1 Diabetes
- Bromocriptine
- Placebo
-
Aurora, ColoradoUniversity of Colorado-Denver, Anshutz Medical Campus
Aug 16, 2021
Overall and Disease Specific Survival in Confirmed MEN1 With or
Active, not recruiting
- Genetic Mutation
- MEN1
- Chart Review
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 21, 2019
Tumors, Pituitary Tumors Trial in Philadelphia (OTL38)
Terminated
- Neoplasms
- Pituitary Neoplasms
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Aug 2, 2019
Pituitary Adenoma Trial (Drug treatment, Surgery)
Unknown status
- Pituitary Adenoma
- Drug treatment
- Surgery
- (no location specified)
Oct 19, 2018
Pituitary Adenoma Trial in Cardiff (PET imaging)
Unknown status
- Pituitary Adenoma
- PET imaging
-
Cardiff, United KingdomUniversity Hospital of Wales
Jan 24, 2019
Invasive Prolactinomas Involving the Cavernous Sinus Trial in China
Unknown status
- Invasive Prolactinomas Involving the Cavernous Sinus
-
Beijing, Beijing, China
- +7 more
May 15, 2017
Non-functioning Pituitary Adenomas, Prolactinomas Trial in Rio de Janeiro (Pasireotide, cabergoline)
Completed
- Non-functioning Pituitary Adenomas
- Prolactinomas
-
Rio de Janeiro, RJ, BrazilEndocrinology Section - Hospital Universitário Clementino Fraga
Jul 21, 2016
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (BIIB019 (Daclizumab), trivalent seasonal influenza vaccine)
Completed
- Relapsing-Remitting Multiple Sclerosis
- BIIB019 (Daclizumab)
- trivalent seasonal influenza vaccine
-
Brno, Czechia
- +64 more
Apr 11, 2018